For what it’s worth, the AstraZeneca solution was successful at preventing severe cases of COVID-19, and remained effective in reducing mortality rates. However, its impact on mild and moderate cases is minimal, preventing illness in just 22% of the patients sampled. The Economic Times of India has confirmed that SA is looking to return these shots.
The Serum Institute of India, which produces the AstraZeneca vaccines, is expected to collect the consignment. The jabs can then be redistributed to countries where the SA variant isn’t dominant, reducing transmission in a more effective manner. The good news for South Africans, however, is that other major inoculations are now on their way to our shores.